“According to the latest report, Hongyun Pharmaceutical (Guizhou) Co., Ltd.'s exclusive Miao medicine Yifei Zhike Capsule has been developed by 30 experts using evidence-based medicine methods to establish a consensus, which clarifies its syndrome characteristics, disease staging, dosage, course of treatment, and combination therapy in the treatment of acute/chronic bronchitis and pulmonary tuberculosis, providing scientific basis for rational clinical application.”